MyAverix Finance
SHG · Healthcare
Qingdao Vland Biotech Co Ltd (603739)
Biotechnology
Qingdao Vland Biotech Co Ltd (603739) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $3.73B, P/E ratio is 44.70, net margin is 6.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603739
Qingdao Vland Biotech Co Ltd (603739) — FAQ
What is Qingdao Vland Biotech Co Ltd's market cap?
Qingdao Vland Biotech Co Ltd (603739) has a reported market cap of $3.73B (data as of 2026-03-29).
What is 603739's P/E ratio?
The price-to-earnings (P/E) ratio for Qingdao Vland Biotech Co Ltd (603739) is 44.70 (data as of 2026-03-29).
Does Qingdao Vland Biotech Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Qingdao Vland Biotech Co Ltd (603739). Check the MyAverix Finance app for the latest dividend data.
What sector is Qingdao Vland Biotech Co Ltd in?
Qingdao Vland Biotech Co Ltd (603739) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 603739 listed on?
603739 is listed on SHG.
What is Qingdao Vland Biotech Co Ltd's net margin?
Qingdao Vland Biotech Co Ltd (603739) reports a net margin of 6.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.